[The first experience of the use the Russian Β-interferon-1b biosimilar (infibeta) in the daily practice of the Moscow Center of Multiple Sclerosis]. [electronic resource]
Producer: 20140123Description: 93-6 p. digitalISSN:- 1997-7298
- Adjuvants, Immunologic -- administration & dosage
- Adolescent
- Adult
- Child
- Dose-Response Relationship, Drug
- Drug Administration Schedule
- Female
- Follow-Up Studies
- Humans
- Injections, Subcutaneous
- Interferon beta-1b
- Interferon-beta -- administration & dosage
- Male
- Middle Aged
- Moscow
- Multiple Sclerosis -- drug therapy
- Recombinant Proteins
- Retrospective Studies
- Treatment Outcome
- Young Adult
No physical items for this record
Publication Type: Comparative Study; English Abstract; Journal Article; Randomized Controlled Trial
There are no comments on this title.
Log in to your account to post a comment.